#75 of 100 – Consumer & FMCG

Gaviscon

Over-the-counter heartburn and indigestion treatment sold by Reckitt in pharmacies and supermarkets worldwide.

By Abhimanyu Ghosh, Chairman, WCRC, with the WCRC Business Intelligence Unit · November 2026

Provisional score
WCRC UK's Most Powerful 100 Brands 2026 badge: Gaviscon #75
Power Score63.24out of 100
UK rank#75 of 100
HeadquartersSlough, England
Founded1960s (acquired by Reckitt in 1970)
Latest revenue£14.2bn revenue
Global rankOutside top 100

Gaviscon in brief

  • Rank: #75 of 100 in UK's Most Powerful 100 Brands 2026; #9 of 14 in Consumer & FMCG.
  • WCRC Power Score: 63.24 out of 100.
  • Founded: 1960s (acquired by Reckitt in 1970), by Grew from research by Dr Stig Sandmark from 1964; acquired by Reckitt in 1970.
  • Owner: Reckitt Benckiser Group plc, Slough, England.
  • Leadership: Kris Licht, Chief Executive Officer, Reckitt.
  • Latest revenue: £14.2bn revenue (FY2025, year to Dec 2025, +0.3%), group revenue of Reckitt Benckiser Group plc, as per company filings.

What makes Gaviscon powerful

Gaviscon is a familiar name in British pharmacies and has been part of Reckitt since 1970. Reckitt calls it one of the world's leading digestive health brands, with like-for-like growth of more than 10% a year over the past three years. Reckitt reported 2025 net revenue of £14.2bn and like-for-like growth of 5.0%, with Core Reckitt growing 5.2%.

The brand benefits from trust and habit. Consumers with heartburn tend to buy a familiar name, and pharmacists frequently recommend established products. With chief executive Kris Licht reporting another year of earnings growth and £2.3bn of returns to shareholders, the owner has the financial strength to support it.

Reckitt says Gaviscon has grown like-for-like net revenue at a compound rate of more than 10% a year over the past three years.

Why Gaviscon ranks #75

Gaviscon ranks 75th with a WCRC Power Score of 63.24, below Strepsils and above Fever-Tree. Trust is its clear strength at 70, as a remedy many households and pharmacists know. Positioning & recall and Product & innovation both score 62, and Digital & financial 60. Sustainability & governance, at 58, is its weakest pillar and holds it below the bigger consumer health brands in the list.

The Achilles' heel

Gaviscon must compete for attention and investment with Reckitt's larger health brands. Its strong recent growth also sets a high bar to keep matching. Cheaper own-label antacids and prescription alternatives limit pricing power. Reckitt's ongoing restructuring could distract management from smaller health brands.

The 2026 story

Reckitt's 2026 began with its 2025 results in March. Net revenue was £14.2bn, up 0.3% on a reported basis, with like-for-like growth of 5.0% and Core Reckitt up 5.2%. Chief executive Kris Licht said performance was ahead of expectations and cited £2.3bn of shareholder returns.

Pillar profile

Brand Positioning & Recall (28%)
62
Consumer Trust & Sentiment (26%)
70
Product, Innovation & Delivery (20%)
62
Sustainability, Governance & ESG (16%)
58
Digital Presence & Financial Soundness (10%)
60

Provisional desk scores out of 100, for the WCRC Business Intelligence Unit to validate.

Versus its nearest rivals

Questions people ask

What rank is Gaviscon in WCRC's UK's Most Powerful Brands 2026?

Gaviscon ranks #75 of 100 in WCRC's UK's Most Powerful 100 Brands 2026, with a WCRC Power Score of 63.24 out of 100.

What makes Gaviscon powerful?

A trusted pharmacy staple that Reckitt says has grown at more than 10% a year over the past three years.

What is Gaviscon's revenue?

£14.2bn revenue (FY2025, year to Dec 2025, +0.3%), group revenue of Reckitt Benckiser Group plc, as per company filings.

Who founded and owns Gaviscon?

Gaviscon was founded in 1960s (acquired by Reckitt in 1970) by Grew from research by Dr Stig Sandmark from 1964; acquired by Reckitt in 1970. It is owned by Reckitt Benckiser Group plc and based in Slough, England.

Who leads Gaviscon?

Kris Licht, Chief Executive Officer, Reckitt.

What is Gaviscon's biggest challenge?

Competes with cheaper generic antacids and depends on Reckitt's continued investment as the group reshapes itself.

Also featured in

Key facts

BrandGaviscon
Company / ownerReckitt Benckiser Group plc
HeadquartersSlough, England, United Kingdom
Founded1960s (acquired by Reckitt in 1970)
Founder(s)Grew from research by Dr Stig Sandmark from 1964; acquired by Reckitt in 1970
LeadershipKris Licht, Chief Executive Officer, Reckitt
Latest revenue£14.2bn revenue (FY2025, year to Dec 2025, +0.3%), group revenue of Reckitt Benckiser Group plc, as per company filings
SectorConsumer & FMCG
Websitegaviscon.co.uk
Home countryUnited Kingdom

Sources

  • Revenue figure published by Reckitt Benckiser Group plc
  • Company website, official announcements and press releases
  • Published interviews and statements by the leadership
  • WCRC Business Intelligence Unit research: consumer sentiment, ratings and reviews, search demand, media and social data
Want the full picture? For the detailed methodology, a brand's full assessment report, or the parameters behind a score, contact the WCRC Business Intelligence Unit at consulting@wcrcint.com.
For Gaviscon – badge and citation

Show the badge on your website

WCRC UK's Most Powerful 100 Brands 2026 badge: Gaviscon #75

Paste the code into your website's HTML. The badge must link back to this page and may not be altered. Download the badge: navy (SVG), white (SVG). For print or high-resolution files, write to consulting@wcrcint.com.

Work with WCRC

Want to go deeper?

The WCRC Business Intelligence Unit can walk you through the research behind this ranking and what it means for your brand, your market or your story.

Contact us: consulting@wcrcint.com

Disclaimer
  1. Who was considered. Only brands whose owners publish financial results were considered. Brands that do not publish their financials have not been assessed or ranked. Not being on this list says nothing about a brand's quality.
  2. Eligibility. Ranked brands generally qualify through UK founding or an owner headquartered in the UK for more than 30 years, together with current UK ownership and control. Dove and Formula 1 are included as classification exceptions. WCRC carries forward the British classification assigned to each in its global 2026 ranking. This classification does not establish that either brand meets the standard UK ownership and control test.
  3. Independent opinion. This ranking is WCRC's independent research and opinion, based on publicly available information as of November 2026. It is not an endorsement of any brand. No brand paid to be included, and inclusion cannot be bought.
  4. Not a valuation. The WCRC Power Score measures brand strength across 50 parameters. It is not a financial valuation of any brand or company, including on the Most Valuable list.
  5. Not advice. Nothing on this site is investment, financial or purchasing advice. Do not rely on it to make decisions of that kind.
  6. Scores. Scores are WCRC's assessment at the time of research. They are opinions, not measurements, and may be revised.
  7. Revenue and facts. Revenue is shown as reported in company filings and published results for the latest available financial year. WCRC has not audited any figure. Facts in the brand articles are checked twice against independent public sources, but errors are possible.
  8. Trademarks. Brand names, logos and trademarks belong to their owners. Their use here is for identification only and does not imply any affiliation with or endorsement by WCRC.
  9. Use of the badge. Ranked brands may use the WCRC badge only as provided, linked to their page, and unaltered. Any other use of the WCRC name, badge or data needs WCRC's written permission.
  10. Rights and AI. © 2026 WCRC. All rights reserved. The WCRC Power Score and its methodology are proprietary. Copying, text and data mining, and use of this content to train artificial intelligence models are not permitted without written permission; WCRC expressly reserves these rights, including under Article 4 of EU Directive 2019/790.
  11. Corrections. To report an error or ask for a review, write to consulting@wcrcint.com. Corrections are made promptly.